BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Villaflor VM, Allaix ME, Minsky B, Herbella FA, Patti MG. Multidisciplinary approach for patients with esophageal cancer. World J Gastroenterol 2012; 18(46): 6737-6746 [PMID: 23239911 DOI: 10.3748/wjg.v18.i46.6737]
URL: https://www.wjgnet.com/1007-9327/full/v18/i46/6737.htm
Number Citing Articles
1
Daniel Vallböhmer, Leila Sisic, Susanne Blank, Sebastian Kraus, Nikolas H. Stoecklein, Wolfram T. Knoefel, Markus W. Büchler, Katja Ott. Clinically Staged cT2 Adenocarcinomas of the Gastroesophageal Junction: Accuracy of Staging and Therapeutic ConsequencesOncology Research and Treatment 2014; 37(3): 97 doi: 10.1159/000360177
2
Jian-Cheng Li, Yun-Hui Zhao, Xiao-Ying Wang, Yan Yang, Ding-Long Pan, Zi-Dan Qiu, Ying Su, Jian-Ji Pan. Clinical significance of the expression of EGFR signaling pathway-related proteins in esophageal squamous cell carcinomaTumor Biology 2014; 35(1): 651 doi: 10.1007/s13277-013-1089-0
3
Fernando A. M. Herbella, Rafael M. Laurino Neto, Marco E. Allaix, Marco G. Patti. Extended Lymphadenectomy in Esophageal Cancer is DebatableWorld Journal of Surgery 2013; 37(8): 1757 doi: 10.1007/s00268-013-2018-5
4
W. H. Ji, Y. H. Jiang, Y. L. Ji, B. Li, W. M. Mao. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapyDiseases of the Esophagus 2016; 29(5): 403 doi: 10.1111/dote.12322
5
Christian Vay, Stefan B. Hosch, Nikolas H. Stoecklein, Christoph A. Klein, Daniel Vallböhmer, Björn-Christian Link, Emre F. Yekebas, Jakob R. Izbicki, Wolfram T. Knoefel, Peter Scheunemann, Lucia R. Languino. Integrin Expression in Esophageal Squamous Cell Carcinoma: Loss of the Physiological Integrin Expression Pattern Correlates with Disease ProgressionPLoS ONE 2014; 9(11): e109026 doi: 10.1371/journal.pone.0109026
6
Y. Hu, Z. Li, D.-H. Mi, N. Cao, S.-W. Zu, Z.-Z. Wen, X.-L. Yu, Y. Qu. Chemoradiation combined with regional hyperthermia for advanced oesophageal cancer: a systematic review and meta-analysisJournal of Clinical Pharmacy and Therapeutics 2017; 42(2): 155 doi: 10.1111/jcpt.12498
7
J. Cools-Lartigue, D. Jones, J. Spicer, T. Zourikian, M. Rousseau, E. Eckert, T. Alcindor, M. Vanhuyse, J. Asselah, L. E. Ferri. Management of Dysphagia in Esophageal Adenocarcinoma Patients Undergoing Neoadjuvant Chemotherapy: Can Invasive Tube Feeding be Avoided?Annals of Surgical Oncology 2015; 22(6): 1858 doi: 10.1245/s10434-014-4270-9
8
Jun Wang, Jun Zhang, Xueying Qiao, Qun Zhao, Yong Li, Bibo Tan, Yuan Tian, Peigang Yang, Gaofeng Shi, Qian Xu, Ruxun Li, Yueping Liu. Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal JunctionThe American Journal of the Medical Sciences 2015; 349(6): 472 doi: 10.1097/MAJ.0000000000000476
9
Chengshi Wang, Juan Pu, Hanxu Yu, Yanyan Liu, Honghuan Yan, Zhongxiang He, Xin Feng. A Dendritic Cell Vaccine Combined With Radiotherapy Activates the Specific Immune Response in Patients With Esophageal CancerJournal of Immunotherapy 2017; 40(2): 71 doi: 10.1097/CJI.0000000000000155
10
Zhi-Qiang Wang, De-Shen Wang, Feng-Hua Wang, Chao Ren, Qiong Tan, Yu-Hong Li. Recombinant human endostatin plus paclitaxel/nedaplatin for recurrent or metastatic advanced esophageal squamous cell carcinoma: a prospective, single-arm, open-label, phase II studyInvestigational New Drugs 2021; 39(2): 516 doi: 10.1007/s10637-020-01021-1
11
Marina ZAMUNER, Fernando A. M. HERBELLA, José L. B. AQUINO. STANDARDIZED CLINICAL PATHWAYS FOR ESOPHAGECTOMY ARE NOT A REALITY IN BRAZIL, EVEN WITH A HIGH PREVALENCE OF ESOPHAGEAL CANCER AND ACHALASIAABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2015; 28(3): 190 doi: 10.1590/S0102-67202015000300011
12
Zhi-Min Ye, Shu-Jun Dai, Feng-Qin Yan, Lei Wang, Jun Fang, Zhen-Fu Fu, Yue-Zhen Wang. DCE-MRI-Derived Volume Transfer Constant (Ktrans) and DWI Apparent Diffusion Coefficient as Predictive Markers of Short- and Long-Term Efficacy of Chemoradiotherapy in Patients With Esophageal CancerTechnology in Cancer Research & Treatment 2018; 17: 153303461876525 doi: 10.1177/1533034618765254
13
Nan Zhang, Shao-wei Zhang. Long-term effects of radiation prior to surgery and chemotherapy on survival of esophageal cancer undergoing surgeryMedicine 2019; 98(43): e17617 doi: 10.1097/MD.0000000000017617
14
Abraham Khan, Richard Carmona, Morris Traube. Dysphagia in the ElderlyClinics in Geriatric Medicine 2014; 30(1): 43 doi: 10.1016/j.cger.2013.10.009
15
R. M. Modi, S. Mikhail, K. Ciombor, K. A. Perry, A. Hinton, P. P. Stanich, C. Zhang, D. L. Conwell, S. G. Krishna. Outcomes of nutritional interventions to treat dysphagia in esophageal cancer: a population-based studyDiseases of the Esophagus 2017; 30(11): 1 doi: 10.1093/dote/dox101
16
Sumin Shin, Hong Kwan Kim, Yong Soo Choi, Kwhanmien Kim, Young Mog Shim. Clinical stage T1–T2N0M0 oesophageal cancer: accuracy of clinical staging and predictive factors for lymph node metastasis†European Journal of Cardio-Thoracic Surgery 2014; 46(2): 274 doi: 10.1093/ejcts/ezt607
17
Xinghan Liu, Lijie Yin, Sunan Shen, Yayi Hou. Inflammation and cancer: paradoxical roles in tumorigenesis and implications in immunotherapiesGenes & Diseases 2021;  doi: 10.1016/j.gendis.2021.09.006
18
Bo-Chang Wu, Angela Ting-Wei Hsu, Sanaz Nourmohammadi Abadchi, Christopher R. Johnson, Sameer Bengali, Frank Lay, Kelsey Melinosky, Chunbo Shao, Kai-Hua Chang, Louis J. Born, John Abraham, David Evans, Jinny S. Ha, John W. Harmon. Potential Role of Silencing Ribonucleic Acid for Esophageal Cancer TreatmentJournal of Surgical Research 2022;  doi: 10.1016/j.jss.2022.04.029
19
Q. Gao, L. Yuan, W.-P. Wang, H. Shi, L.-Q. Chen. Factors influencing response enthusiasm to telephone follow-up in patients with oesophageal carcinoma after oesophagectomyEuropean Journal of Cancer Care 2014; 23(3): 310 doi: 10.1111/ecc.12143